Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$5.06 – $7.49
2% from low
Exchange
OTC Link
ADRC
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.49B | $5.10B | $5.34B | $4.93B | $6.06B | $6.59B | $7.21B | $7.52B |
| Cost of revenue | $2.44B | $2.76B | $3.08B | $2.97B | $3.83B | $4.10B | $4.42B | $4.67B |
| Gross profit | $2.05B | $2.34B | $2.26B | $1.96B | $2.21B | $2.49B | $2.79B | $2.86B |
| Gross margin | 45.7% | 45.9% | 42.2% | 39.8% | 36.5% | 37.8% | 38.7% | 38.0% |
| R&D | $240.7M | $276.0M | $294.2M | $354.9M | $361.1M | $395.3M | $384.0M | $409.2M |
| Operating income | $994.1M | $1.13B | $996.1M | $595.1M | $782.4M | $799.4M | $1.19B | $1.25B |
| EBITDA | $1.22B | $1.44B | $1.30B | $922.3M | $1.21B | $1.18B | $1.48B | $1.64B |
| Net income | $596.6M | $625.1M | $618.5M | $188.7M | $208.3M | $59.3M | $156.9M | $386.0M |
| Net margin | 13.3% | 12.3% | 11.6% | 3.8% | 3.4% | 0.9% | 2.2% | 5.1% |
| EPS (diluted) | 0.44 | 0.46 | 0.45 | 0.14 | 0.16 | 0.04 | 0.12 | 0.28 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $7.8B | $0.42 | $0.40–$0.43 | 1 |
| 2027 | $8.3B | $0.54 | $0.52–$0.56 | 1 |
| 2028 | $8.7B | $0.70 | $0.67–$0.72 | 1 |
| 2029 | $9.3B | $0.78 | $0.75–$0.80 | 1 |
Forward consensus · source: Financial Modeling Prep
GRIFOLS SA S/ADR
No one on the platform currently holds GIKLY.
No tracked institution reports a position in GIKLY as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-07-02 | $0.0472 | 2026-07-09 |
| 2025-08-12 | $0.0879 | 2025-08-20 |
| Execution date | Ratio |
|---|---|
| 2016-01-04 | 2-for-1 |
| 2012-12-11 | 41-for-40 |
No one on the platform has traded GIKLY yet.
| $11.2B |
| — |
| FMCQFFresenius Medical Care AG | $45.17 | +0.00% | $12.1B | — |
| ORINFOrion Oyj | $82.75 | +0.00% | $11.7B | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 35.9× earnings vs its 42.5× historical median P/E.
Fair value ≈ $6.04 · price $5.09 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.